Special Apple-Fi Update: The Future of the Internet

By Ray BlancoPosted October 7, 2020

Apple-fi is heating up. The space industryAlso today, I want to take some time to answer some of your most pressing Apple-Fi-related questions.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Technology Profits Confidential Pro

Ray Blanco’s VIP Tech Advantage

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Golden Buy Opportunity for Our Position

By Ray BlancoPosted August 28, 2020

Shortsighted selling has exposed a huge golden buy opportunity for one of our positions. That means only good news for you — especially if you haven’t bought into it yet, or are considering adding more to your currentposition.

The Potential Remains Unabated in This Leukemia Play

By Ray BlancoPosted March 17, 2016

If this company succeeds at curing patients, we should see it trading at a multiple to today's share price. One recent 500% jump has shown us a clear example of the kinds of gains we could eventually see…

Next-Generation Antibody Companies Ink New Partnership Deals — Plus, 2 Sells

By Ray BlancoPosted January 10, 2014

In biotechnology, one way to get a feel for a new therapeutic platform's potential for success is relationships. A really promising platform will generally attract the attention of other players who want a piece of the action. Big Pharma has essentially “pharmed out” a lot of the drug discovery and development it used to do with emerging biotech companies. But if one of the new upstarts is truly promising in the opinion of the experts working at these companies, a couple of things can happen. One is a partnership, either on an existing drug under development at the junior company or for a collaboration to use that company's technology to develop a drug that doesn't exist yet. The second thing, of course, is an outright buyout of the smaller firm.

Riding The Next Green Wave

By Ray BlancoPosted August 16, 2019

One of the premier cannabis company has seen shares sell-off recently, which gives us a great buying opportunity! And today, Ray explains just how this pot stock is positioning itself to dominate the global marijuana market…

This Weekend, Our Biotechs Waltzed Along the Beautiful Blue Danube

By Ray BlancoPosted October 5, 2012

Last week, I mentioned that several of our companies were presenting at the European Society for Medical Oncology's (ESMO) annual meeting over the weekend. For biotechnology companies working on new cancer cures, this is one of the year's biggest events...

Transgalactic Tourism on the Horizon

By Ray BlancoPosted December 13, 2019

Ray is on the go once again and this time he’s landed in Sin City. But instead of hitting the slots he’ll be making contacts and checking out the facilities of up and coming cannabis companies. Plus, there’s a new, out of this world travel company that you need to know about…

Login